收藏切换
Bioequivalence study of desloratadine tablets in healthy Chinese subjects
收藏切换
PDF
Peng-fei XIE1, Yuan-lu CHEN1, Hong-di CUI1, Hui LONG1, Yong-gang ZHAO1, Qi-shan HUANG2, Peng YANG3, Yan ZHOU3, Yong-dong ZHANG1
Chinese Journal of Clinical Pharmacology | 2025, 41(2) : 220 - 224
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(2): 220-224
Pharmacokinetics and Bioequivalence Study
Bioequivalence study of desloratadine tablets in healthy Chinese subjects
Full
Peng-fei XIE1, Yuan-lu CHEN1, Hong-di CUI1, Hui LONG1, Yong-gang ZHAO1, Qi-shan HUANG2, Peng YANG3, Yan ZHOU3, Yong-dong ZHANG1
Affiliations
  • 1.Phase Ⅰ Clinical Centre, Chenzhou No.1 People’s Hospital, Chenzhou 423000, Hunan Province, China
  • 2.Anhui Menjie Technology Development Co., Ltd, Hefei 230601, Anhui Province, China
  • 3.Anhui Wanbang Pharmaceutical Technology Co., Ltd, Hefei 230000, Anhui Province, China
Published: 2025-01-28 doi: 10.13699/j.cnki.1001-6821.2025.02.014
Outline
收藏切换
Objective

To explore the pharmacokinetic (PK) characteristics of desloratadine tablets and reference drugs in healthy subjects, and evaluate their bioequivalence and safety.

Methods

The random, open, two-period, cross-over pharmacokinetic study method was adopted, each subject received a single oral dose of desloratadine tablets test drug(T) or reference drug(R) for 5 mg. The concentrations of desloratadine and 3-hydroxy desloratadine in plasma were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS); and the PK parameters were calculated by WinNonlin 8.1 software to evaluate the bioequivalence.

Results

The main PK parameters of T and R of desloratadine were as follows: the fasting condition Cmax were respectively (3 809.82±1 016.54) and (3 642.36±777.07) pg·mL-1; AUC0-120h were respectively (5.75×104±5.03×104) and (5.51×104±4.00×104) pg·h·mL-1; AUC0-∞ were respectively (6.85×104±1.03×104) and (6.37×104±7.92×104) pg·h·mL-1. The fed condition Cmax were respectively (4 398.98±1 191.22) and (4 744.40±1 511.97) pg·mL-1; AUC0-120 h were respectively(5.25×104±1.82×104) and (5.55×104±1.98×104) pg·h·mL-1; AUC0-∞ were respectively(5.37×104±1.86×104) and (5.68×104±2.04×104) pg·h·mL-1. The 90% confidence interval of Cmax, AUC0-t and AUC0-∞ of desloratadine were all within 80.00%~125.00%.

Conclusion

There was no significant difference in the main PK parameters between T and R under fasting or high-fat postprandial conditions, and desloratadine tablets were bioequivalent, safe and well tolerated.

desloratadine tablet  /  healthy Chinese subject  /  pharmacokinetic  /  bioequivalence
Peng-fei XIE, Yuan-lu CHEN, Hong-di CUI, Hui LONG, Yong-gang ZHAO, Qi-shan HUANG, Peng YANG, Yan ZHOU, Yong-dong ZHANG. Bioequivalence study of desloratadine tablets in healthy Chinese subjects[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (2) : 220 -224 . DOI: 10.13699/j.cnki.1001-6821.2025.02.014
Year 2025 volume 41 Issue 2
PDF
1
0
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.02.014
  • Receive Date:2024-06-30
  • Online Date:2026-08-04
  • Published:2025-01-28
Article Data
Affiliations
History
  • Received:2024-06-30
Funding
Affiliations
    1.Phase Ⅰ Clinical Centre, Chenzhou No.1 People’s Hospital, Chenzhou 423000, Hunan Province, China
    2.Anhui Menjie Technology Development Co., Ltd, Hefei 230601, Anhui Province, China
    3.Anhui Wanbang Pharmaceutical Technology Co., Ltd, Hefei 230000, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.02.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT